Clinical results of extracorporeal photopheresis

N Worel, G Leitner - Transfusion Medicine and Hemotherapy, 2012 - karger.com
Extracorporeal photopheresis (ECP) is a combination of leukapheresis and photodynamic
therapy in which blood is treated with photoactivable drugs which are then activated with …

[引用][C] Wirkung der Extrakorporalen Photopherese unter Berücksichtigung spezifischer Verlaufsparameter bei Progressiver Systemischer Sklerodermie und …

S Reich-Schupke - 2004 - Bochum, Univ., Diss., 2004

Current Research of Extracorporeal Photopheresis and Future Applications

C Lederer - The Science Journal of the Lander College of …, 2014 - touroscholar.touro.edu
Photopheresis, also known as Extracorporeal Photopheresis (ECP) is making inroads in
treatment of previously untreatable diseases. As the medical world has delved deeper into …

Extracorporeal photopheresis: a case of immunotherapy ahead of its time

PA Vieyra-Garcia, P Wolf - Transfusion Medicine and Hemotherapy, 2020 - karger.com
Extracorporeal photopheresis (ECP) is a cell-based immunotherapy that involves the
reinfusion of autologous leukocytes after exposure to psoralen and UVA. The treatment has …

Extracorporeal photopheresis for the treatment of autoimmune diseases

J Adamski, T Kinard, T Ipe, L Cooling - Transfusion and Apheresis Science, 2015 - Elsevier
The immune system is tasked with the unique challenge of recognizing foreign pathogens
and damaged cells while at the same time preserving and protecting the integrity of “self” …

Continual advancements in the innovative field of extracorporeal photochemotherapy: Time to wake up, to shake up, to shape up the future direction

J Seghatchian, I Sniecinski - Transfusion and Apheresis Science, 2015 - trasci.com
Allogeneic haematopoietic stem cell transplantation [HSCT] is the established therapeutic
option for many patients with malignant and non-malignant diseases, but despite …

Extracorporeal Photopheresis and Its Use in Clinical Dermatology in Canada

F Lagacé, E Netchiporouk, I Turchin, W Gulliver… - Skin Therapy …, 2022 - europepmc.org
Extracorporeal photopheresis (ECP) is an immunomodulatory therapy that has been used
for over 35 years to treat numerous conditions. ECP was initially approved by the US FDA in …

[HTML][HTML] A Randomized Single− Blind Study of Extracorporeal Photopheresis with UVADEX® Plus Conventional Therapy (CT) Compared to CT Alone in Chronic …

MED Flowers, K Van Besien, J Apperley, A Bacigalupo… - Blood, 2006 - Elsevier
Chronic GVHD (cGVHD) is a major limitation of allogeneic hematopoietic cell
transplantation. Extracorporeal photopheresis therapy (ECP) has been used in retrospective …

Increasing the collection flow rate to 2 mL/min is effective and reduces the procedure time in off‐line photopheresis

W Mayer, J Mayr, F Koch, U Rechberger… - …, 2023 - Wiley Online Library
Background Extracorporeal photopheresis (ECP) treatment, mostly based on apheresis
technology, is used for immunomodulation in various diseases such as cutaneous T‐cell …

Photopheresis: current and future perspectives

EC Vonderheid - Journal of Cutaneous Medicine and Surgery …, 2003 - Springer
Extracorporeal photopheresis (ECP), also known as extracorporeal photochemotherapy or
photoimmunotherapy, is the brainchild of Richard Edelson, MD, currently Professor and …